Covaxin, Covishield Produce Fewer Antibodies Against B.1.617 But Potent Against Other Covid-19 Variants
South Africa in the news: Covaxin, Covishield Produce Fewer Antibodies Against B.1.617 But Potent Against Other Covid-19 Variants: The two vaccines- Covaxin and Covishield were designed on the blueprint of the virus variant, called B1, that became the dominant strain in India by last April.: “South Africa” – BingNews India and US discuss revised proposal …